Literature DB >> 2331765

Outcome after a "perfect" Fontan operation.

F Fontan1, J W Kirklin, G Fernandez, F Costa, D C Naftel, F Tritto, E H Blackstone.   

Abstract

A study was undertaken to determine the early and long-term outcomes dictated by the Fontan state per se (a state in which the force driving pulmonary blood flow is solely or largely a residue, in the systemic venous pressure, of the main ventricular chamber's contractile force) and the transition (by surgery) to it from the state of congenital heart disease under optimal conditions (after a "perfect" Fontan operation). The primary study design used a solution of a multivariate risk factor equation for death, by which survival rate under optimal conditions was predicted to be 92%, 89%, 88%, 86%, 81%, and 73% at 1 month, 6 months, and 1, 5, 10, and 15 years, respectively, after the Fontan operation. The hazard function (instantaneous risk of death at each moment in time after the operation) had an early rapidly declining phase of hazard that at about 6 months began to give way to a late hazard phase, which was rising by about 6 years after surgery. A secondary study design, using the theory of competing risks, yielded survival and hazard function information very similar to that of the primary study design. The functional capacity of the patients as expressed by New York Heart Association class was less, the longer the period of follow-up. No risk factors (other than older age at time of surgery) were found for the late decline in survival or the decline in functional status. The inference is that the premature decline in survival and functional status and the late rise in hazard function are from the Fontan state per se and that the Fontan operation is, therefore, palliative but not curative.

Entities:  

Mesh:

Year:  1990        PMID: 2331765     DOI: 10.1161/01.cir.81.5.1520

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  65 in total

Review 1.  Echocardiography in adult congenital heart disease.

Authors:  A Houston; S Hillis; S Lilley; T Richens; L Swan
Journal:  Heart       Date:  1998-11       Impact factor: 5.994

2.  Surgical therapy for the univentricular heart.

Authors:  R Sharma
Journal:  Indian J Pediatr       Date:  2000-07       Impact factor: 1.967

3.  Effects of arteriovenous shunt on ventricular function in dog.

Authors:  T Omoto; R Aeba; T Katogi; T Ito; S Kawada
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1999-03

4.  Recent modifications of the fontan procedure for complex congenital heart disease.

Authors:  G J Reul; I D Gregoric
Journal:  Tex Heart Inst J       Date:  1992

Review 5.  Computer modeling to tailor therapy for congenital heart disease.

Authors:  Michael A Quail; Andrew M Taylor
Journal:  Curr Cardiol Rep       Date:  2013-09       Impact factor: 2.931

6.  Sequelae after modified Fontan operation: postoperative haemodynamic data and organ function.

Authors:  R Kaulitz; I Luhmer; F Bergmann; B Rodeck; G Hausdorf
Journal:  Heart       Date:  1997-08       Impact factor: 5.994

7.  Site of coronary sinus drainage does not significantly affect coronary flow reserve in patients long term after Fontan operation.

Authors:  A Eicken; W Sebening; T Genz; H Kaemmerer; R Lange; R Busch; J Hess
Journal:  Pediatr Cardiol       Date:  2006 Jan-Feb       Impact factor: 1.655

Review 8.  Long-term results of the Fontan operation.

Authors:  D J Driscoll
Journal:  Pediatr Cardiol       Date:  2007 Nov-Dec       Impact factor: 1.655

9.  Heart Failure in Adults who had the Fontan Procedure: Natural History, Evaluation, and Management.

Authors:  Ari Cedars; Susan Joseph; Philip Ludbrook
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-10

10.  Tricuspid Atresia with Non-compaction: An Early Experience with Implications for Surgical Palliation.

Authors:  Hoang H Nguyen; Rabia Khan; Norman H Silverman; Gautam K Singh
Journal:  Pediatr Cardiol       Date:  2016-12-10       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.